Home
Public services
Dashboard
Curated content
Startups & Scaleups
New startups
Job board
Corporates
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
More organizations
Matching tool
Investment heatmap
Themes
Reports
Companies
Arxx Therapeutics
Save
Arxx Therapeutics
Develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis.
Overview
Similar companies
Investments (0)
Analytics
Notes
Job openings
Innovations (0)
Recent News about Arxx Therapeutics
Edit